MGC Pharmaceuticals's total assets for Q4 2022 were $18.56M, a decrease of -23.43% from the previous quarter. MGCLF total liabilities were $13.38M for the fiscal quarter, a 28.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.